---
title: "By the end of 2024, 30% of global clinical trials will come from China, and China's development rate in the biopharmaceutical field far exceeds the past"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241639603.md"
description: "On May 23rd, Cynthia L. VERST, President of R&D Solutions Design and Delivery Innovation at IQVIA, stated at the Zhangjiang Science and Technology Innovation Salon Global Innovation Leaders Special Session that by the end of 2024, 30% of clinical trials will come from China, 35% from the United States, and a small portion from Europe. The 30% in China represents a significant increase and is growing every year. We see that China's overall development rate globally far exceeds the past"
datetime: "2025-05-23T13:43:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241639603.md)
  - [en](https://longbridge.com/en/news/241639603.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241639603.md)
generator: "portal-rs"
---

# By the end of 2024, 30% of global clinical trials will come from China, and China's development rate in the biopharmaceutical field far exceeds the past

On May 23rd, Cynthia L. VERST, President of R&D Solutions Design and Delivery Innovation at IQVIA, stated at the Zhangjiang Science and Technology Innovation Salon Global Innovation Leaders session that by the end of 2024, 30% of clinical trials will come from China, 35% from the United States, and a small portion from Europe. The 30% in China represents a significant increase and is growing every year. We see that China's overall development rate globally far exceeds that of the past

### Related Stocks

- [IQV.US](https://longbridge.com/en/quote/IQV.US.md)
- [399441.CN](https://longbridge.com/en/quote/399441.CN.md)

## Related News & Research

- [GRAPHIC-Take Five: AI trade meets the Fed](https://longbridge.com/en/news/302836715.md)
- [Oracle Stocks Edge Up as $1 Billion Backs AI Partners](https://longbridge.com/en/news/302919901.md)
- [IREN Stock: Why Analysts Still See Over 200% Upside Despite This Week's Plunge](https://longbridge.com/en/news/302922686.md)
- [Why Did Analysts Slash Bloom Energy Stock (BE) Price Targets Despite Praising Q3 Earnings Beats?](https://longbridge.com/en/news/302920834.md)
- [Western Digital Q1 Revenue Surges 55% YoY, Shares Drop Nearly 7%: Can $330 Support Hold?](https://longbridge.com/en/news/302840204.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**